Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
Jesús Rivera‐Esteban, Sergio Muñoz, Mónica Higuera, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1774-1789.e8
Closed Access | Times Cited: 10

Showing 10 citing articles:

A Global Perspective on Metabolically Driven Primary Liver Cancer: Opportunities and Challenges
Joseph Ahn
The American Journal of Gastroenterology (2025)
Closed Access
18F-FDG PET/CT predicts the prognosis of patients with hepatocellular carcinoma undergoing liver transplantation
Wen-Jing Zheng, Yang Xu, Hui Shan Tan, et al.
Liver Cancer (2025), pp. 1-27
Open Access
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Díaz, Juan Pablo Arab, Francisco Idalsoaga, et al.
Annals of Hepatology (2025), pp. 101903-101903
Open Access
Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure
Elena Vargas‐Accarino, Mónica Higuera, Marı́a Buti, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1521-1521
Open Access | Times Cited: 3
Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional Mendelian randomized study
Weiyu Liang, Kunting Zhong, Tingting Lai, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies
Tian Lan, Frank Tacke
Metabolism (2024) Vol. 161, pp. 156015-156015
Open Access | Times Cited: 1
Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification
Heechul Nam, Pil Soo Sung, Sung Won Lee, et al.
Liver Cancer (2024), pp. 1-18
Open Access
Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
Zahid Ijaz Tarar, Umer Farooq, Faisal Inayat, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Open Access
Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos‐Molina
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access
Refining Nomenclature in Fatty Liver Disease: The Need for „MetVir” in Metabolic and Viral Overlap
Abdulrahman Ismaiel, Stefan‐Lucian Popa, Dan L. Dumitrașcu
Journal of Gastrointestinal and Liver Diseases (2024) Vol. 33, Iss. 4, pp. 441-443
Open Access
Page 1

Scroll to top